KalVista Pharmaceuticals, Inc.

Historical 13F Holders

Symbol
KALV
CUSIP
483497103
All holders as of
Q1 2025
Type
Equity
Class
COM
Reported Value, Excluding Options
Total Filings
Period Filings Shares, Excl. Options Value, Excl. Options
2025 Q1 141 54.9 M $640 M
2024 Q4 134 55.2 M $467 M
2024 Q3 129 48.4 M $561 M
2024 Q2 126 48.6 M $572 M
2024 Q1 137 47.9 M $568 M
2023 Q4 112 37.5 M $460 M
2023 Q3 112 36.3 M $349 M
2023 Q2 100 34.5 M $310 M
2023 Q1 91 33.7 M $265 M
2022 Q4 97 35.0 M $239 M
2022 Q3 101 25.6 M $372 M
2022 Q2 95 24.3 M $239 M
2022 Q1 94 24.3 M $364 M
2021 Q4 103 23.8 M $315 M
2021 Q3 113 23.4 M $408 M
2021 Q2 120 24.3 M $583 M
2021 Q1 127 23.6 M $605 M
2020 Q4 97 16.7 M $310 M
2020 Q3 66 16.2 M $204 M
2020 Q2 74 16.0 M $194 M
2020 Q1 72 15.9 M $122 M
2019 Q4 76 13.9 M $247 M
2019 Q3 79 13.7 M $159 M
2019 Q2 79 14.8 M $329 M
2019 Q1 71 13.9 M $399 M
2018 Q4 59 13.4 M $263 M
2018 Q3 51 12.7 M $278 M
2018 Q2 27 6.34 M $51.5 M
2018 Q1 26 6.55 M $62.0 M
2017 Q4 24 6.48 M $63.2 M
2017 Q3 18 7.72 M $52.2 M
2017 Q2 18 7.37 M $54.1 M
2017 Q1 21 7.59 M $59.2 M
2016 Q4 21 7.33 M $51.5 M